Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 309  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
This article has been cited by
1Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development
Li Zhou,Yu-Ling Shi,Kai Li,Iltefat Hamzavi,Tian-Wen Gao,Richard H. Huggins,Henry W. Lim,Qing-Sheng Mi
Pigment Cell & Melanoma Research.2015;28(3)324
[DOI]
2The Role of Tumor Necrosis Factor-a in the Pathogenesis of Vitiligo
Carlos R. Camara-Lemarroy,Julio C. Salas-Alanis
American Journal of Clinical Dermatology.2013;14(5)343
[DOI]
3Predominant role of innate pro-inflammatory cytokines in vitiligo disease
Nasser Gholijani,Mohammad-Reza Yazdani,Ladan Dastgheib
Archives of Dermatological Research.2020;312(2)123
[DOI]
4Altered expression of nuclear factor of activated T cells, forkhead box P3, and immune-suppressive genes in regulatory T cells of generalized vitiligo patients
Prashant S. Giri,Mitesh Dwivedi,Naresh C. Laddha,Rasheedunnisa Begum,Ankit H. Bharti
Pigment Cell & Melanoma Research.2020;312(2)123
[DOI]
5The therapeutic effects of EGCG on vitiligo
Yiping Zhu,Suiquan Wang,Fuquan Lin,Qing Li,Aie Xu
Fitoterapia.2014;99(2)243
[DOI]
6The therapeutic effects of EGCG on vitiligo
Jillian M. Richmond,John E. Harris
Fitoterapia.2017;99(2)511
[DOI]
7Increased systemic and epidermal levels of IL-17A and IL-1ß promotes progression of non-segmental vitiligo
Supriya Bhardwaj,Seema Rani,Niharika Srivastava,Ravinder Kumar,Davinder Parsad
Cytokine.2017;91(2)153
[DOI]
8Topical methotrexate 1% gel for treatment of vitiligo: A case report and review of the literature
Ayman Abdelmaksoud,Dharmendra Dineshchandra Dave,Torello Lotti,Michelangelo Vestita
Dermatologic Therapy.2019;32(5)153
[DOI]
9Correlation between IL-36a and IL-17 and Activity of the Disease in Selected Autoimmune Blistering Diseases
Agnieszka Zebrowska,Anna Wozniacka,Katarzyna Juczynska,Kamila Ociepa,Elzbieta Waszczykowska,Izabela Szymczak,Rafal Pawliczak
Mediators of Inflammation.2017;2017(5)1
[DOI]
10DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders
Razia Rahman,Isha Sharma,Lokesh K. Gahlot,Yasha Hasija
Biomedical Dermatology.2018;2(1)1
[DOI]
11Pediatric Vitiligo
Nanette B. Silverberg
Pediatric Clinics of North America.2014;61(2)347
[DOI]
12RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis
Konduru Seetharama Sastry,Haroon Naeem,Younes Mokrab,Aouatef Ismail Chouchane
Oxidative Medicine and Cellular Longevity.2019;2019(2)1
[DOI]
13Recent advances in childhood vitiligo
Nanette B. Silverberg
Clinics in Dermatology.2014;32(4)524
[DOI]
14Cytokine profile ( IL -2, IL -6, IL -17, IL -22, and TNF -a) in vitiligo—New insight into pathogenesis of disease
Sushama Sushama,Niharika Dixit,Ram Krishna Gautam,Pooja Arora,Ananta Khurana,Anubhuti Anubhuti
Journal of Cosmetic Dermatology.2019;18(1)337
[DOI]
15Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves’ disease
CUIGE LIANG,WENHUA DU,QINGYU DONG,XIAOMENG LIU,WENXIA LI,YUELI WANG,GUANQI GAO
Experimental and Therapeutic Medicine.2015;9(3)925
[DOI]
16T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo
Manoj Kumar Tembhre,Vinod Kumar Sharma,Alpana Sharma,Parthaprasad Chattopadhyay,Somesh Gupta
Clinica Chimica Acta.2013;424(3)27
[DOI]
17The role of interleukins in vitiligo: a systematic review
I.A. Gomes,F.O. de Carvalho,A.F. de Menezes,F.M. Almeida,S. Shanmugam,J. de Souza Siqueira Quintans,L.J. Quintans-Júnior,T.R. de Moura,P.D. Oliveira,A.A. de Souza Araújo
Journal of the European Academy of Dermatology and Venereology.2018;32(12)2097
[DOI]
18Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease
Emina Kasumagic-Halilovic,Semra Cavaljuga,Nermina Ovcina-Kurtovic,Lamija Zecevic
Skin Appendage Disorders.2018;4(4)286
[DOI]
19Decreased regulatory T-cells and CD4+/CD8+ratio correlate with disease onset and progression in patients with generalized vitiligo
Mitesh Dwivedi,Naresh C. Laddha,Prateek Arora,Yogesh S. Marfatia,Rasheedunnisa Begum
Pigment Cell & Melanoma Research.2013;26(4)586
[DOI]
20Serum prolactin levels in dermatological diseases: A case–control study
Nadia Abdalhafid Elsherif,Abdalla I. El-Sherif,Salwa A. El-Dibany
Journal of Dermatology & Dermatologic Surgery.2015;19(2)104
[DOI]
21Ocular mucous membrane pemphigoid: a review
Samanta Taurone,Marialuisa Spoletini,Massimo Ralli,Pietro Gobbi,Marco Artico,Laszlň Imre,Cecília Czakň,Illés Kovŕcs,Antonio Greco,Alessandra Micera
Immunologic Research.2019;67(2-3)280
[DOI]
22Association of IFN-??:?IL-10 Cytokine Ratio with Nonsegmental Vitiligo Pathogenesis
Yaswanth Ala,Mohammed Khalid Pasha,Raja Narasimha Rao,Prasanna Latha Komaravalli,Parveen Jahan
Autoimmune Diseases.2015;2015(2-3)1
[DOI]
23A Quantitative Increase in Regulatory T Cells Controls Development of Vitiligo
Shilpak Chatterjee,Jonathan M. Eby,Amir A. Al-Khami,Myroslawa Soloshchenko,Hee-Kap Kang,Navtej Kaur,Osama S. Naga,Anuradha Murali,Michael I. Nishimura,I. Caroline Le Poole,Shikhar Mehrotra
Journal of Investigative Dermatology.2014;134(5)1285
[DOI]
24The combination of tumour necrosis factor-a -308A and interleukin-10 -1082G gene polymorphisms and increased serum levels of related cytokines: susceptibility to vitiligo
I. E. Aydingöz,M. Kanmaz-Özer,A. Gedikbasi,P. Vural,S. Dogru-Abbasoglu,M. Uysal
Clinical and Experimental Dermatology.2015;40(1)71
[DOI]
25Ameliorative effects of fruit stem extract from Muscat Bailey A against chronic UV-induced skin damage in BALB/c mice
Byoung Ok Cho,Denis Nchang Che,Jae Young Shin,Hyun Ju Kang,Seon Il Jang
Biomedicine & Pharmacotherapy.2018;97(1)1680
[DOI]
26Cytokines: the yin and yang of vitiligo pathogenesis
Mala Singh,Ashwin Kotnis,Shahnawaz D. Jadeja,Anushree Mondal,Mohmmad S. Mansuri,Rasheedunnisa Begum
Expert Review of Clinical Immunology.2019;15(2)177
[DOI]
27Association of Angiotensin-Converting Enzyme (ACE) Gene Polymorphism with Inflammation and Cellular Cytotoxicity in Vitiligo Patients
Laila Rashed,Rania Abdel Hay,Rania Mahmoud,Nermeen Hasan,Amr Zahra,Salwa Fayez,Alessandro Giuffrč
PLOS ONE.2015;10(7)e0132915
[DOI]
28CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study
Marwa Abdallah,Medhat El-Mofty,Tag Anbar,Hoda Rasheed,Samia Esmat,Amira Al-Tawdy,Marwa M. Fawzy,Dalia Abdel-Halim,Rehab Hegazy,Heba Gawdat,Dalia Bassiouny,Mona A. Ibrahim,Iman Sany,Mahy El-Bassiouny,Mohamed Khalil,Abeer Abdel-Aziz,Zeinab M. El Maadawi,Wedad Z. Mostafa
Pigment Cell & Melanoma Research.2018;31(2)330
[DOI]
29The role of flavonoids in autoimmune diseases: Therapeutic updates
Kannan R.R. Rengasamy,Haroon Khan,Shanmugaraj Gowrishankar,Ricardo J.L. Lagoa,Fawzi M. Mahomoodally,Ziyad Khan,Shanoo Suroowan,Devesh Tewari,Gokhan Zengin,Sherif T.S. Hassan,Shunmugiah Karutha Pandian
Pharmacology & Therapeutics.2019;194(2)107
[DOI]
30Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo
John E. Harris
Immunological Reviews.2016;269(1)11
[DOI]
31Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo
Rehab A. Karam,Haidy E. Zidan,Mohamed H. Khater
Biochemistry and Cell Biology.2017;95(4)474
[DOI]
32Tumour necrosis factor-a inhibition can stabilize disease in progressive vitiligo
K.C. Webb,R. Tung,L.S. Winterfield,A.B. Gottlieb,J.M. Eby,S.W. Henning,I.C. Le Poole
British Journal of Dermatology.2015;173(3)641
[DOI]
  Search 
  The Journal 
  The Association 
  Dermalinks  
  Book of Abstracts 
  Site Statistics 
  Addresses 
  My Preferences 
  Online Submission 

Submit Articles

Alerts